Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation-Reference-Cited by-同舟云学术

Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation

Published:2008-02 Issue:2 Volume:27 Page:141-149
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Zuckermann Andreas,Manito Nicolas,Epailly Eric,Fiane Arnt,Bara Christoph,Delgado Juan F.,Lehmkuhl Hans,Ross Heather,Eisen Howard,Chapman Jeremy,Valantine Hannah

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference72 articles.

1. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts;Schachner;Ann Thorac Surg,2004

2. Everolimus reduces intimal proliferation in an ex vivo model of vascular injury;Cornelissen;J Heart Lung Transplant,2006

3. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German–Austrian Certican Consensus Conference;Rothenburger;J Heart Lung Transplant,2007

4. Clinical pharmacokinetics of everolimus;Kirchner;Clin Pharmacokinet,2004

5. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years—a randomized clinical trial;Keogh;Circulation,2004

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients;The Journal of Heart and Lung Transplantation;2023-05

2. The International Society for Heart and Lung Transplantation (ISHLT) Guidelines for the Care of Heart Transplant Recipients;The Journal of Heart and Lung Transplantation;2022-12

3. Outcomes and Impact on Life Quality;Heart Transplantation;2022

4. Complete remission from post-heart transplant lymphoproliferative disorder: A case report;Journal of Cardiology Cases;2021-08

5. A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study);Transplantation;2020-02